Limited studies have examined the role of EGFR and its ligands in angiogenesis in the normal vasculature, whereas a large body of literature in the cancer field documents a link between EGFR and vascular endothelial growth factor (VEGF), a well-known initiator of angiogenesis. Here, VEGFA is linked to cancer.